The need to eat is initiated, in part, by a hormone known as ghrelin. Although ghrelin is known to be produced in the gut and to trigger the brain to promote eating, it remains to be determined precisely how ghrelin affects different parts...

Although Parkinson's disease is most commonly viewed as a "movement disorder," scientists have found that the disease also causes widespread abnormalities in touch and vision side effects that have now been verified using functional magnet...

Neurologix, Inc. (OTCBB: NRGX), a biotech company engaged in the development of innovative gene therapies for disorders affecting the brain and central nervous system, announced today that it has successfully completed its landmark Phase I...

"I am a vulgar man. But I assure you, my music is not," says Mozart's character in the movie "Amadeus." No one doubts the second part of that statement, but the first remains controversial. Some have suggested that Mozart suffered from Tou...

Malaria is not usually thought of as a major disease in the Middle East, but a study from Yemen in this week's BMJ reveals worryingly high levels of severe malaria in children. In fact, the figures show that as many as 4 out of 10 children...

What goes first in the wasting disease known as amyotrophic lateral sclerosis: the muscles or the neurons that control them? Most researchers have assumed that the neurons die off, starting the process of muscle wasting. But the story may...

Leon Thal, Director of the Shiley-Marcos Alzheimer's Disease Research Center at UCSD, heads 70-site consortium funded by National Institutes of Health The Alzheimer's Disease Cooperative Study (ADCS), a federally established consortium dir...

People who carry a particular genetic variation are more likely to respond to stress by becoming depressed and by ruminating on the event, according to a study by researchers at Yale School of Medicine, Stony Brook University, and the Univ...

PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery and development of small-molecule drugs targeting post-transcriptional control processes, today announced encouraging data from a Phase 2 clinical trial of...

Newly published cognitive function data from a large, two-year trial published in the November issue of Kidney International report on the effects of chronic kidney disease (CKD) on cognitive function in CKD Stage 5 patients with hyperphos...